Product logins

Find logins to all Clarivate products below.


Renal Anemia in Chronic Kidney Disease Non-Dialysis | Chart Trends | China | 2014

Through an in-depth review of patient charts, details such as product dosing and titration, switching, concomitant medications and a host of laboratory and patient demographic variables help define patient types and identify therapy triggers.
The attitudinal survey component allows for a better understanding of the rationale for treatment decisions and gaps between intended and actual treatment. By comparing what nephrologists report about patient care dynamics to actual treatment records, gaps in intended care versus actual care are uncovered and patient segments become more clearly defined.

Related Market Assessment Reports

Report
Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Geographic Focus: China – Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – China In-Depth (China)
The NHL therapy market in China is poised for significant growth over the next decade, driven by the introduction of novel therapies and the continued uptake and label expansion of premium-priced…
Report
GLP-1 receptor agonists – China In-Depth – GLP-1 Receptor Agonists – China In-Depth – China
China’s GLP-1 receptor agonist market is set for robust expansion, driven by the rising prevalence of type 2 diabetes (T2D), obesity, and comorbidities such as chronic kidney disease (CKD) and…
Report
Biosimilars – Geographic Focus: China – Biosimilars – China In-Depth (China)
China’s biosimilar market has transformed significantly since February 2019, following the approval of Shanghai Henlius Biotech’s HLX01—a biosimilar of Roche’s MabThera (rituximab). The…
Report
Non-Small-Cell Lung Cancer – Geographic Focus: China – China In-Depth – Non-Small-Cell Lung Cancer
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related mortality in China. Treatment is based on biomarker status; patients with EGFR- and ALK-positive tumors generally receive…
Report
Breast Cancer – Geographic Focus: China – China In-Depth – Breast Cancer
The breast cancer therapy market in mainland China is one of the most dynamic in the oncology sector. Several new and emerging therapies are expected to gain approval for specific subpopulations,…